Skip to main content
ROVI Subsidiaries
Spain
Germany
France
Italy
Poland
Portugal
United Kingdom
Language
Spanish
Spanish
English
English
English
Español
Home
ROVI
History
Group structure
Business units
International expansion
Strategy
Licenses
Contact
Products
Prescription Pharmaceuticals
Hospital Products
Manufacturing
CDMO
Own product Manufacturing
R&D
Shareholders and Investors
The share
Investor's Calendar
News
Financial and Business Information
CMNV Communications
ESG
Corporate Governance
Telematic assistance access
Prior Registration On-Line Attendance
On-Line Attendance
Sustainability
Responsible governance
Commitment to people
Environmental Commitment
Ethics Channel
Media
FAQS
News
ROVI up to date
Contact
Work with Us
TELEMATIC ASSISTANCE ACCESS
Home
>
Shareholders and investors
> News
News
Find out more about ...
The Share
Investor's Calendar
News
Financial and Business Information
Public Statements Sent to CNMV
ESG
Corporate Governance
News searcher
Year
Year
-Year
2025
2024
2023
2022
2021
2020
2019
Sort by
Fecha publicación
Order
Asc
Desc
2012 First Half Results Presentation
0 min
26 Jul, 2012
2012 First Quarter Results
0 min
26 Apr, 2012
2012 First Quarter Results Presentation
0 min
26 Apr, 2012
2011 full year results press release
0 min
21 Feb, 2012
2011 full year results presentation
0 min
21 Feb, 2012
Corlentor® receives approval for use in heart failure
0 min
15 Feb, 2012
9M 2011 Interim Statement
0 min
08 Nov, 2011
Nine-month period ended 30 September 2011 Results Presentation
0 min
08 Nov, 2011
Results of the final analysis of the ABEL Phase II clinical trial
0 min
19 Oct, 2011
See more
